Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes
Research and Practice in Thrombosis and Haemostasis · 2026
DOI: 10.1016/j.rpth.2026.106929 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2026. Verfasst von Eleonora Camilleri und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Thrombosis, Blood Proteins, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon Europe.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
- Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
- Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
- Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
- Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.
- Division of Thrombosis and Hemostasis, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
Förderung
- Horizon Europe
Zitieren
APA
Camilleri, E., Vladic, N., Englisch, C., Steiner, D., Preusser, M., Berghoff, A. S., Fuereder, T., Berger, J. M., Ruhaak, L. R., Cannegieter, S. C., van Vlijmen, B. J. M., Klok, F. A., & Ay, C. (2026). Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2026.106929
Vancouver
Camilleri E, Vladic N, Englisch C, Steiner D, Preusser M, Berghoff AS, et al. Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes. Research and Practice in Thrombosis and Haemostasis. 2026. doi:10.1016/j.rpth.2026.106929
BibTeX
@article{Camilleri2026,
author = {Camilleri, Eleonora and Vladic, Nikola and Englisch, Cornelia and Steiner, Daniel and Preusser, Matthias and Berghoff, Anna S and Fuereder, Thorsten and Berger, Julia M and Ruhaak, L Renee and Cannegieter, Suzanne C and van Vlijmen, Bart J M and Klok, Frederikus A and Ay, Cihan},
title = {Distinct changes in plasma protein profiles of cancer patients receiving immune checkpoint inhibitors versus chemotherapy: implications for thrombosis risk and adverse outcomes},
journal = {Research and Practice in Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.rpth.2026.106929}
}
EUVIMED